Regenxbio (RGNX) Other Accumulated Expenses (2014 - 2026)
Regenxbio (RGNX) posted quarterly Other Accumulated Expenses of $757000.0 for Q4 2025, up 16.64% year-over-year from $649000.0 in Q4 2024, and down 18.51% quarter-over-quarter from $929000.0 in Q3 2025.
Regenxbio (RGNX) Other Accumulated Expenses (2014 - 2026) Analysis & Trends
Regenxbio's Other Accumulated Expenses history runs 12 years deep, the most recent figure standing at $757000.0 for Q4 2025.
- In Q4 2025, Other Accumulated Expenses rose 16.64% year-over-year to $757000.0; the TTM figure through Dec 2025 stood at $757000.0 (up 16.64% YoY), while the FY2025 annual figure was $757000.0, up 16.64% from the prior year.
- Other Accumulated Expenses for Q4 2025 stood at $757000.0, down from $929000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $999000.0 in Q1 2023, with the low at $122000.0 in Q1 2021.
- The 5-year median for Other Accumulated Expenses is $748000.0 (2022), against an average of $697500.0.
- Peak annual rise in Other Accumulated Expenses reached 363.44% in 2021, while the deepest fall reached 58.64% in 2021.
- Regenxbio's Other Accumulated Expenses stood at $744000.0 in 2021, then rose by 0.27% to $746000.0 in 2022, then tumbled by 38.61% to $458000.0 in 2023, then surged by 41.7% to $649000.0 in 2024, then climbed by 16.64% to $757000.0 in 2025.
- Business Quant data shows RGNX's Other Accumulated Expenses at $757000.0 in Q4 2025, $929000.0 in Q3 2025, and $736000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Regenxbio | 583.35 Mn | 477.83 Mn | 106.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 753,000.00 |
| Dec 31, 2025 | 757,000.00 |
| Sep 30, 2025 | 929,000.00 |
| Jun 30, 2025 | 736,000.00 |
| Mar 31, 2025 | 779,000.00 |
| Dec 31, 2024 | 649,000.00 |
| Sep 30, 2024 | 787,000.00 |
| Jun 30, 2024 | 591,000.00 |
| Mar 31, 2024 | 993,000.00 |
| Dec 31, 2023 | 458,000.00 |
| Sep 30, 2023 | 861,000.00 |
| Jun 30, 2023 | 883,000.00 |
| Mar 31, 2023 | 999,000.00 |
| Dec 31, 2022 | 746,000.00 |
| Sep 30, 2022 | 952,000.00 |
| Jun 30, 2022 | 750,000.00 |
| Mar 31, 2022 | 338,000.00 |
| Dec 31, 2021 | 744,000.00 |
| Sep 30, 2021 | 445,000.00 |
| Jun 30, 2021 | 431,000.00 |